May News Roundup: What’s New in Research?

Stem Cells Edited to Fight Arthritis – Read More >

Researchers at the Washington University School of Medicine and Shriners Hospitals for Children have rewired stem cells from mice in an effort to reduce inflammation caused by arthritis and other conditions. These stem cells are developed into cartilage cells that produce a biologic anti-inflammatory drug that may be able to replace arthritic cartilage, protecting joints and other tissues from further damage.

Research Moves Closer to Unraveling Mystery Cause of Multiple Sclerosis – Read More >

An international team of researchers has discovered a defect in brain cells that may cause Multiple Sclerosis (MS). The study, which was published in the Journal of Neuroinflammation, has addressed a largely unknown aspect of MS. This discovery may also pave the way for research to investigate new treatments for those with MS, a population of about 2.5 million individuals worldwide.

AHA Brings Latest Research On Heart Disease Out of the Lab and Into Older American’s Homes – Read More >

The American Heart Association is working with the home care provider Honor to take heart disease and stroke research into the homes of patients. Home health care professionals will be provided with science-based information so that they can better treat their patients. This initiative is one example of the growing movement to broaden the impact of clinical trials.

Novel Compound Blocks Replication of Zika and Other Viruses – Read More >

Researchers may be one step closer to controlling outbreaks of Zika and other viruses such as Chikungunya and Dengue. The study, which was published in mBio, reveals a novel compound that triggers cells’ innate antiviral system. Cells of vertebrates have developed pathways that create an internal defense, inhibiting infections by preventing replication of pathogens.

New Blood Test Offers Potential for Faster, Targeted Treatment of NSCLC – Read More >

Patients who are suspected to have NSCLC typically receive an invasive tissue biopsy in order to diagnose their condition. A new blood test reported in The Journal of Molecular Diagnostics may simplify this process by quickly identifying gene mutations associated with NSCLC. Additionally, community-based practices that don’t have access to hospitals with diagnosis/treatment facilities will be able to test their patients for NSCLC.

Looking for more research news? Check out these resources:

CenterWatch News Online

World Pharma News

Applied Clinical Trials